SCHEMBL1644348

SCHEMBL1644348

CCNc1ccc(C(C)=O)nc1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HTT P42858 2/20 0.38
GAA P10253 2/20 0.38
HPGD P15428 2/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
GFER P55789 1/20 0.38
PLEC Q15149 1/20 0.38
TSHR P16473 2/20 0.36
CYP3A4 P08684 1/20 0.36
RECQL P46063 1/20 0.36
IDO1 P14902 2/20 0.35
HCAR3 P49019 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
P2RX7 Q99572 1/20 0.34
PGK1 P00558 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1475555 0.75 MMP2 (0.46) KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL3580429 0.71 NOS3 (0.43) KDM4EALDH1A1GAAMAPTL3MBTL1
SCHEMBL1642783 0.71 LMNA (0.38) KDM4EALDH1A1HTTGAAHPGD
SCHEMBL24251774 0.69 IAPP (0.43) KDM4EALDH1A1HPGDMAPTTSHR
SCHEMBL27380679 0.69 SMN1; SMN2 (0.35) KDM4EALDH1A1HTTGAAHPGD
SCHEMBL2943654 0.69 KDM4E (0.45) KDM4EALDH1A1HTTGAAHPGD
SCHEMBL10915624 0.68 HSD17B10 (0.40) KDM4EALDH1A1HPGDMAPTTHRB
SCHEMBL30845964 0.68 RAB9A (0.42) KDM4EALDH1A1HTTMAPTL3MBTL1
SCHEMBL21241047 0.68 KDM4E (0.39) KDM4EALDH1A1HTTGAAL3MBTL1
SCHEMBL23112473 0.68 KDM4E (0.39) KDM4EALDH1A1MAPTL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088746-A1 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME PFIZER INC. (US) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088746-A1 AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME TRPV1, TRPA1, TRPV2 KDM4E 4075/4885ALDH1A1 1265/4885HTT 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.